A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer-Reference-Cited by-同舟云学术

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer

Published:2021-09-30 Issue:12 Volume:15 Page:3348-3362
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Berg Inge¹^ORCID,Smid Marcel²,Coebergh van den Braak Robert R. J.¹^ORCID,Wiel Mark A.³,Deurzen Carolien H. M.⁴,Weerd Vanja²,Martens John W. M.²,IJzermans Jan N. M.¹,Wilting Saskia M.²

Affiliation:

1. Department of Surgery Erasmus MC ‐ University Medical Center Rotterdam The Netherlands

2. Department of Medical Oncology Erasmus MC Cancer Institute University Medical Center Rotterdam The Netherlands

3. Department of Epidemiology & Data Science Amsterdam University Medical Center Amsterdam Public Health research institute The Netherlands

4. Department of Pathology Erasmus MC – University Medical Center Rotterdam The Netherlands

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13098

Reference52 articles.

1. The consensus molecular subtypes of colorectal cancer

2. Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes

3. Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors

4. Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

5. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors;British Journal of Cancer;2024-09-04

2. Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer;BMC Cancer;2023-07-03

3. A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes;Cancers;2023-05-26

4. MOPA: An integrative multi-omics pathway analysis method for measuring omics activity;PLOS ONE;2023-03-16

5. Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers;Cancers;2022-02-06